The global cervical cancer diagnostic market was valued at $7.8 billion in 2022, and is projected to reach $12.7 billion by 2032, growing at a CAGR of 5% from 2023 to 2032.
Report Code : A00304 | Pages : 228 | Category : Life Sciences
Membrane technology is a mechanical separation process that involves the separation of liquid or gaseous stream by using permeable membranes. It is superior to conventional separation process as ...
Report Code : A00307 | Category : Life Sciences
The global arthroscopy devices market was valued at $18.0 billion in 2020, and is projected to reach $41.9 billion by 2030, growing at a CAGR of 8.5% from 2021 to 2030.
Report Code : A00329 | Pages : 210 | Category : Life Sciences
Sexually transmitted diseases spread through sexual contact. The cause of these diseases may be bacterial, fungal, viral or protozoa infections. The major types of these diseases include Chlamydia, ...
Report Code : A00334 | Category : Life Sciences
The market for small animal imaging (In-Vivo) is expected to reach at $2.1 billion by 2020. Imaging modalities emerged as a preferred option for the clinical industry, especially ...
Report Code : A00375 | Pages : 162 | Category : Life Sciences
Cancer genome sequencing refers to a method used to identify the complete DNA or RNA sequence of cancer cells based on the sequencing of a single, homogeneous or ...
Report Code : A00391 | Category : Life Sciences
The global spectrometry market was valued at $11.1 billion in 2021, and is projected to reach $20.3 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031.
Report Code : A00411 | Pages : 225 | Category : Life Sciences
The global telemedicine market was valued at $84.3 billion in 2022, and is projected to reach $451.4 billion by 2032, growing at a CAGR of 18.3% from 2023 to 2032.
Report Code : A00412 | Pages : 273 | Category : Life Sciences
Yersinia is a rod-shaped, gram positive bacterium in the Enterobacteriaceae family that causes enterocolitis, terminal iletis, mesenteric lymphadenitis, acute diarrhea and sepsis. The pathogen species of Yersinia include Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis. These species of Yersinia cause the Bubonic plague and gastroenteritis respectively
Report Code : A00417 | Category : Life Sciences
The global metabolomics market size was valued at $2,032 Million in 2020, and is projected to reach $6,663 Million by 2030, registering a CAGR of 12.2% from 2021 ...
Report Code : A00423 | Pages : 270 | Category : Life Sciences
Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism’s body that causes disturbances in normal functioning. Immunology is the study of the human body’s resistance to these infections.
Report Code : A00431 | Category : Life Sciences
The global RNA based therapeutics market size generated $4,938.38 million in 2021, and is projected to reach $25,121.95 million by 2030, growing at a CAGR of 17.6% from ...
Report Code : A00443 | Pages : 170 | Category : Life Sciences
DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant ...
Report Code : A00445 | Category : Life Sciences
Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.
Report Code : A00463 | Category : Life Sciences
The early toxicity testing market accounted for $739 million in 2017, and is expected to reach $1,301 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.
Report Code : A00500 | Pages : 210 | Category : Life Sciences
The global macular edema and macular degeneration market size was valued at $8,301 million in 2020, and is projected to reach $16,530 million by 2030, registering a CAGR ...
Report Code : A00501 | Pages : 210 | Category : Life Sciences
There is an impending need for renewable sources of energy in order to maintain the sustainability of the environment. One such advancement is the emergence of biorefinery application ...
Report Code : A00531 | Category : Life Sciences
The End User segment in South Africa Digital PCR Market is expected to garner considerable share in terms of value and volume during the forecast period.
Report Code : A00532 | Pages : 210 | Category : Life Sciences
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases
Report Code : A00533 | Category : Life Sciences
Testing of blood is one of the oldest and most widely used techniques to rule out the presence of any disease. Blood tests are used to assure the ...
Report Code : A00537 | Category : Life Sciences
Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
Report Code : A00538 | Category : Life Sciences
The global stroke management market was valued at $36.1 billion in 2022, and is projected to reach $74 billion by 2032, growing at a CAGR of 7.4% from 2022 to 2032.
Report Code : A00539 | Pages : 230 | Category : Life Sciences
The global DNA vaccine market size was valued at $422.77 Million in 2020 and is projected to reach $774.43 Million by 2030 registering a CAGR of 6.3% from ...
Report Code : A00549 | Pages : 123 | Category : Life Sciences
The global syphilis testing market was valued at $1.1 billion in 2020, and is projected to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.
Report Code : A00553 | Pages : 200 | Category : Life Sciences
The global specialty enzymes market was valued at $1.2 billion in 2021, and is projected to reach $2.2 billion by 2031, growing at a CAGR of 6.7% from 2022 to 2031.
Report Code : A00575 | Pages : 245 | Category : Life Sciences
